Roland Valdes, Jr., Ph.D., DABCC, FACB – President
Dr. Valdes is a professor and senior vice-chairman of the Department of Pathology and Laboratory Medicine, professor of biochemistry and molecular biology, and holds the appointment of Distinguished University Scholar at the University of Louisville. He is chair of the American Association for Clinical Chemistry committee that recently issued guidelines for the use of genetic information in crafting more effective treatment plans for individual patients. He is a fellow and past-president of the National Academy of Clinical Biochemistry, and past-president of the Clinical Ligand Assay Society. He holds several Distinguished Scientist Awards, has authored over 230 publications in scientific literature, and has mentored, to date, more than 30 trainees in laboratory medicine and research.
Mark W. Linder, Ph.D., DABCC, FACB – Executive Vice President/Operations
Dr. Linder is a professor in the Department of Pathology and Laboratory Medicine at the University of Louisville and assistant director of Clinical Chemistry and Toxicology at the University of Louisville Hospital. He is a fellow of the National Academy of Clinical Biochemistry (NACB) and serves on a number of committees for the American Association for Clinical Chemistry (AACC). His scientific interests include mechanisms for regulation of drug metabolism and bringing the science of both pharmacogenetics and proteomics into clinical laboratory practice. He is the principal inventor of PerMIT, PGXL’s pharmacogenetic diagnostic support software undergoing clinical trials in order to obtain FDA clearance.